ArticleCellular oncology (Dordrecht, Netherlands)2024

SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma.

Zengbin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.